News Home

Press Releases

Supply Update

Subscribe


Downloads
TIMELINE OF INNOVATION

CORPORATE FACT SHEET


Media Contacts

  • Priscilla Harlan
    Senior Director, Corporate Communications
    Lantheus Medical Imaging
    978-671-8854

  • Michele Rozen
    Pure Communications
    617-730-8284

Investor Relations
  • Phone: 978-671-8001
  • Email

Molybdenum-99 Supply Updates

Recent Press Releases
7/15/10 Lantheus Medical Imaging, Inc. Launches DEFINITY® Ultrasound Contrast Imaging Agent in India
7/12/10 Lantheus Medical Imaging, Inc. Purchases Balance of Worldwide Rights for MRA Imaging Agent ABLAVAR® (Gadofosveset Trisodium)
7/08/10 Lantheus Medical Imaging, Inc. Announces Agreement with MDS Nordion to Secure Additional Supply of Molybdenum-99 (Mo-99), a Key Medical Isotope
6/14/10 Lantheus Medical Imaging, Inc. Presents Phase 4 Safety Data on DEFINITY® at American Society of Echocardiography Annual Meeting
6/09/10 Lantheus Medical Imaging, Inc. Presents Preliminary Data on Novel PET Myocardial Perfusion Imaging Agent Protocol at SNM Annual Meeting


© 2010 Lantheus Medical Imaging, Inc.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.
ABLAVAR™, Cardiolite® and DEFINITY® are registered trademarks of Lantheus Medical Imaging, Inc.
Any unlicensed use of these trademarks is expressly prohibited under the U.S. Trademark Act.
Intended for U.S. Residents Only